102 related articles for article (PubMed ID: 10021490)
1. Synthesis and characterisation of poly(D,L-lactic acid)-idoxuridine conjugate.
Rimoli MG; Avallone L; de Caprariis P; Galeone A; Forni F; Vandelli MA
J Control Release; 1999 Mar; 58(1):61-8. PubMed ID: 10021490
[TBL] [Abstract][Full Text] [Related]
2. Controlled release of 3',5'-diester prodrugs of 5-fluoro-2'-deoxyuridine from poly-L-lactic acid microspheres.
Seki T; Kawaguchi T; Endoh H; Ishikawa K; Juni K; Nakano M
J Pharm Sci; 1990 Nov; 79(11):985-7. PubMed ID: 2149864
[TBL] [Abstract][Full Text] [Related]
3. Preparation of Polymeric Prodrug Paclitaxel-Poly(lactic acid)-b-Polyisobutylene and Its Application in Coatings of a Drug Eluting Stent.
Ren K; Zhang M; He J; Wu Y; Ni P
ACS Appl Mater Interfaces; 2015 Jun; 7(21):11263-71. PubMed ID: 25955234
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of mPEG-PLA prodrug micelles.
Hans M; Shimoni K; Danino D; Siegel SJ; Lowman A
Biomacromolecules; 2005; 6(5):2708-17. PubMed ID: 16153110
[TBL] [Abstract][Full Text] [Related]
5. New oligoethylene ester derivatives of 5-iodo-2'-deoxyuridine as dermal prodrugs: synthesis, physicochemical properties, and skin permeation studies.
Bonina FP; Rimoli MG; Avallone L; Barbato F; Amato M; Puglia C; Ricci M; De Caprariis P
J Pharm Sci; 2002 Jan; 91(1):171-9. PubMed ID: 11782906
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, physicochemical properties, and cytotoxicity of a series of 5'-ester prodrugs of 5-iodo-2'-deoxyuridine.
Narurkar MM; Mitra AK
Pharm Res; 1988 Nov; 5(11):734-7. PubMed ID: 3247280
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of the dioleoyl derivative of iododeoxyuridine and its incorporation into reconstituted high density lipoprotein particles.
Bijsterbosch MK; Schouten D; van Berkel TJ
Biochemistry; 1994 Nov; 33(47):14073-80. PubMed ID: 7947817
[TBL] [Abstract][Full Text] [Related]
8. PLA stereocomplexes for controlled release of somatostatin analogue.
Bishara A; Domb AJ
J Control Release; 2005 Oct; 107(3):474-83. PubMed ID: 16140412
[TBL] [Abstract][Full Text] [Related]
9. Oligo(Lactic Acid)
Tam YT; Repp L; Ma ZX; Feltenberger JB; Kwon GS
Pharm Res; 2019 Mar; 36(5):70. PubMed ID: 30888509
[TBL] [Abstract][Full Text] [Related]
10. Modulated release of IdUrd from poly (D,L-lactide-co-glycolide) microspheres by addition of poly (D,L-lactide) oligomers.
Geze A; Venier-Julienne MC; Saulnier P; Varlet P; Daumas-Duport C; Devauchelle P; Benoit JP
J Control Release; 1999 Apr; 58(3):311-22. PubMed ID: 10099156
[TBL] [Abstract][Full Text] [Related]
11. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
12. Design and in vitro assessment of L-lactic acid-based copolymers as prodrug and carrier for intravitreal sustained L-lactate release to reverse retinal arteriolar occlusions.
Veurink M; Asmus L; Hennig M; Kaufmann B; Bagnewski L; Heiligenhaus A; Mendrinos E; Pournaras CJ; Gurny R; Möller M
Eur J Pharm Sci; 2013 May; 49(2):233-40. PubMed ID: 23500039
[TBL] [Abstract][Full Text] [Related]
13. Holmium-loaded poly(L-lactic acid) microspheres: in vitro degradation study.
Zielhuis SW; Nijsen JF; Krijger GC; van het Schip AD; Hennink WE
Biomacromolecules; 2006 Jul; 7(7):2217-23. PubMed ID: 16827590
[TBL] [Abstract][Full Text] [Related]
14. Experimental (IR/Raman and 1H/13C NMR) and theoretical (DFT) studies of the preferential conformations adopted by L-lactic acid oligomers and poly(L-lactic acid) homopolymer.
Jarmelo S; Marques DA; Simões PN; Carvalho RA; Batista CM; Araujo-Andrade C; Gil MH; Fausto R
J Phys Chem B; 2012 Jan; 116(1):9-21. PubMed ID: 22082026
[TBL] [Abstract][Full Text] [Related]
15. Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states.
Kranz H; Ubrich N; Maincent P; Bodmeier R
J Pharm Sci; 2000 Dec; 89(12):1558-66. PubMed ID: 11042603
[TBL] [Abstract][Full Text] [Related]
16. Formation of bioerodible polymeric microspheres and microparticles by rapid expansion of supercritical solutions.
Tom JW; Debenedetti PG
Biotechnol Prog; 1991; 7(5):403-11. PubMed ID: 1369363
[TBL] [Abstract][Full Text] [Related]
17. Effect of enzymatic degradation on the release kinetics of model drug from Pluronic F127/poly(lactic acid) nano-particles.
Xiong XY; Tam KC; Gan LH
J Control Release; 2005 Nov; 108(2-3):263-70. PubMed ID: 16199106
[TBL] [Abstract][Full Text] [Related]
18. Poly(L-lactic acid) microspheres containing neutron-activatable holmium-165: a study of the physical characteristics of microspheres before and after irradiation in a nuclear reactor.
Mumper RJ; Jay M
Pharm Res; 1992 Jan; 9(1):149-54. PubMed ID: 1589401
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol.
Xinteng Z; Weisan P; Ruhua Z; Feng Z
Pharmazie; 2002 Oct; 57(10):695-7. PubMed ID: 12426951
[TBL] [Abstract][Full Text] [Related]
20. Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability.
Giannavola C; Bucolo C; Maltese A; Paolino D; Vandelli MA; Puglisi G; Lee VH; Fresta M
Pharm Res; 2003 Apr; 20(4):584-90. PubMed ID: 12739765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
